iodine i 131 monoclonal antibody cc49-deltach2
mAbexperimentalADC
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 30, 2001 (NCT00025532)
Timeline
2000s
- Jan 1, 2001
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensBINDING AGENT
Tumor antigens binding agent
Chemistry & pharmacology
- Payload
- 131-iodine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00025532 | Phase 1 | Apr 30, 2001 | National Cancer Institute (NCI), University of California, San Francisco |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2001 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2001 |
2 organizations
Page 1 / 1